World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02192047
Date of registration: 24/06/2014
Prospective Registration: No
Primary sponsor: Malaysia Palm Oil Board
Public title: Chronic Effects of Natural and Interesterified Fats Margarine on Insulin Sensitivity and Selected Markers of Cardiovascular Diseases (CVD)
Scientific title: Chronic Effects of Natural Palm-based Margarine and Interesterified Palm- and Soy-based Margarine on Insulin Sensitivity and Selected Markers of Cardiovascular Diseases (CVD)
Date of first enrolment: September 2012
Target sample size: 85
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02192047
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science  
Phase:  N/A
Countries of recruitment
Malaysia
Contacts
Name:     Voon Phooi Tee, Ph.D
Address: 
Telephone:
Email:
Affiliation:  MPOB
Name:     Ng Yen Teng, BSc
Address: 
Telephone:
Email:
Affiliation:  IMU
Key inclusion & exclusion criteria

Inclusion Criteria:

- Adult males and females, aged 20-60 yr

- Staff and students of International Medical University, IMU/ Staff of Malaysian Palm
Oil Board, MPOB to facilitate centralized consumption of the test fats/snacks

- BMI 21 - 30 kg/m2

Exclusion Criteria:

- Abnomal liver function test (elevated transaminases- alanine aminotransferase,ALT;
aspartate aminotransferase,AST))/ abnormal kidney function test (elevated plasma
creatinine)

- History of type 2 diabetes mellitus, cancer, stomach ulcers, drug abuse or alcoholism

- Smokers

- On lipid/blood pressure- lowering medication/supplements

- Blood pressure>140/90 mmHg

- Fasting total cholesterol > 6.5 mmol/L

- Fasting TAG > 2.0 mmol/L

- Candidates who are going abroad during the planned schedule for the dietary
intervention



Age minimum: 20 Years
Age maximum: 60 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Overweight
Intervention(s)
Other: IE Palm olein
Other: Palm Olein
Other: IE soybean oil-based
Primary Outcome(s)
Change in serum C-peptide level of subject [Time Frame: up to 8 weeks]
Secondary Outcome(s)
Change in serum lipid profile [Time Frame: up to 8 weeks]
Change in markers of obesity [Time Frame: up to 8 weeks]
Change in markers of inflammation [Time Frame: up to 8 weeks]
Oral Glucose tolerance test (OGTT) [Time Frame: Baseline, month-2]
Change in markers of insulin resistance [Time Frame: up to 8 weeks]
Secondary ID(s)
PD 174/13
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Universiti Putra Malaysia
International Medical University
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history